Mycoplasma hyorhinis confers chemoresistance to cancer cells by metabolizing gemcitabine into its inactive metabolite, 2′,2′-difluorodeoxyuridine, through its cytidine deaminase (CDD) activity. This evidence concerns the gene CDA and cancer.